Timeline sources
Milestone dates are shown as recorded in the timeline. Publication, enactment and application dates are distinct. Existing source-check dates are not a new certification; standards may require paid access.
37 milestones with official documents · 0 without an official document
37 of 37 milestones
Glossary sources· US
Anti-Kickback Statute enacted
The Social Security Amendments of 1972 introduced criminal penalties for specified kickbacks, bribes and rebates connected with Medicare and Medicaid services.
View timeline milestoneThe original law establishes enactment, not every element of today's broader Anti-Kickback Statute.
- Social Security Amendments of 1972, Public Law 92-603
U.S. government (govinfo.gov)
https://www.govinfo.gov/content/pkg/STATUTE-86/pdf/STATUTE-86-Pg1329.pdf
No recorded date check
- Social Security Amendments of 1972, Public Law 92-603
· US
Medical Device Amendments signed
Expanded FDA authority over medical devices, established three risk classes and the premarket notification and approval framework.
View timeline milestone- FDA: Medical Device Amendments signed
FDA
https://www.fda.gov/about-fda/fda-history-research-tools/selected-food-drug-cosmetic-device-and-tobacco-laws
Recorded source check:
- FDA: Medical Device Amendments signed
· US
IDE regulation scheduled to take effect
21 CFR Part 812 set the rules for investigational device exemptions, letting unapproved devices be used in clinical studies.
View timeline milestonePrinted page 3732 onward. The rule states July 16, 1980 subject to OMB approval; the subsequent approval notice has not been verified.
- FDA IDE final rule, 45 FR 3732 (January 18, 1980)
U.S. government (Federal Register)
https://archives.federalregister.gov/issue_slice/1980/1/18/3693-3761.pdf
No recorded date check
- FDA IDE final rule, 45 FR 3732 (January 18, 1980)
· US
CLIA '88 signed
The Clinical Laboratory Improvement Amendments established federal quality standards for laboratories testing human specimens for diagnosis, prevention or treatment; research-only testing is outside that clinical scope.
View timeline milestone- CMS: CLIA '88 signed
CMS
https://www.cms.gov/newsroom/fact-sheets/medicare-program-clinical-laboratory-improvement-amendments-clia-1988-fees-cms-3356-nc
Recorded source check:
- CMS: CLIA '88 signed
· US
Stark Law enacted
The Ethics in Patient Referrals Act barred physician self-referral for Medicare-covered services, later expanded in 1993.
View timeline milestoneThe original prohibition concerned clinical laboratory services. Enactment is distinct from application, and the codified text includes later amendments.
- OBRA 1989, Public Law 101-239: approval date
U.S. government (ssa.gov)
https://www.ssa.gov/OP_Home/comp2/F101-239.html
- 42 USC 1395nn: physician referral prohibition and statutory history
U.S. government (govinfo.gov)
https://www.govinfo.gov/content/pkg/USCODE-2010-title42/html/USCODE-2010-title42-chap7-subchapXVIII-partE-sec1395nn.htm
No recorded date check
- OBRA 1989, Public Law 101-239: approval date
· US
Safe Medical Devices Act signed
Added device user reporting, postmarket surveillance authority and the Humanitarian Device Exemption.
View timeline milestoneEnactment date, not a common application date for all implementing requirements.
- Safe Medical Devices Act of 1990, Public Law 101-629
U.S. government (govinfo.gov)
https://www.govinfo.gov/content/pkg/STATUTE-104/pdf/STATUTE-104-Pg4511.pdf
No recorded date check
- Safe Medical Devices Act of 1990, Public Law 101-629
· US
HIPAA signed
The Health Insurance Portability and Accountability Act laid the base for federal privacy and security rules for health data.
View timeline milestoneHIPAA enactment, not issuance or compliance dates of the later Privacy and Security Rules.
- HIPAA, Public Law 104-191
U.S. government (govinfo.gov)
https://www.govinfo.gov/content/pkg/PLAW-104publ191/html/PLAW-104publ191.htm
No recorded date check
- HIPAA, Public Law 104-191
· US
Quality System Regulation takes effect
21 CFR Part 820 added design controls to device good manufacturing practice requirements.
View timeline milestonePublished October 7, 1996, effective June 1, 1997. See Section IV for design-control compliance details.
- FDA Quality System Regulation final rule, 61 FR 52602
U.S. government (govinfo.gov)
https://www.govinfo.gov/content/pkg/FR-1996-10-07/html/96-25720.htm
No recorded date check
- FDA Quality System Regulation final rule, 61 FR 52602
· US
FDAMA creates De Novo
The FDA Modernization Act created the De Novo route for novel low to moderate risk devices with no predicate.
View timeline milestone- FDA: FDAMA creates De Novo
FDA
https://www.fda.gov/about-fda/fda-history-research-tools/selected-food-drug-cosmetic-device-and-tobacco-laws
Recorded source check:
- FDA: FDAMA creates De Novo
· US
First device user fees (MDUFMA)
The Medical Device User Fee and Modernization Act introduced user fees tied to FDA review performance goals, renewed every five years.
View timeline milestoneSupports original enactment and the fee framework, not subsequent five-year reauthorizations.
- Medical Device User Fee and Modernization Act of 2002, Public Law 107-250
U.S. government (govinfo.gov)
https://www.govinfo.gov/link/plaw/107/public/250
No recorded date check
- Medical Device User Fee and Modernization Act of 2002, Public Law 107-250
· International
IEC 62304 published
First edition of the software life cycle standard for medical device software.
View timeline milestone- ISO: IEC 62304 published
ISO
https://www.iso.org/standard/38421.html
Recorded source check:
- ISO: IEC 62304 published
· US
HITECH Act signed
Strengthened HIPAA enforcement and introduced breach notification duties for health data.
View timeline milestone- HHS: HITECH Act signed
HHS
https://www.hhs.gov/hipaa/for-professionals/special-topics/hitech-act-enforcement-interim-final-rule/index.html
Recorded source check:
- HHS: HITECH Act signed
· US
Physician Payments Sunshine Act
Passed within the Affordable Care Act, requiring manufacturers to report payments to physicians and teaching hospitals.
View timeline milestoneEnactment within the ACA, not the start of Open Payments reporting or disclosure.
- Affordable Care Act section 6002: physician payment transparency
U.S. government (govinfo.gov)
https://www.govinfo.gov/content/pkg/PLAW-111publ148/html/PLAW-111publ148.htm
No recorded date check
- Affordable Care Act section 6002: physician payment transparency
· US
UDI final rule published
FDA required unique device identifiers on labels and GUDID submissions, phased in by device class.
View timeline milestone- U.S. government (govinfo.gov): UDI final rule published
U.S. government (govinfo.gov)
https://www.govinfo.gov/content/pkg/FR-2013-09-24/html/2013-23059.htm
Recorded source check:
- U.S. government (govinfo.gov): UDI final rule published
· US
NIST Cybersecurity Framework 1.0
A voluntary framework for managing cybersecurity risk, widely used by manufacturers and hospitals. Version 2.0 followed in February 2024.
View timeline milestone- NIST: NIST Cybersecurity Framework 1.0
NIST
https://www.nist.gov/publications/framework-improving-critical-infrastructure-cybersecurity-version-10
Recorded source check:
- NIST: NIST Cybersecurity Framework 1.0
· International
ISO 13485:2016 published
The current edition of the medical device quality management system standard.
View timeline milestone- ISO: ISO 13485:2016 published
ISO
https://www.iso.org/standard/59752.html
Recorded source check:
- ISO: ISO 13485:2016 published
· US
21st Century Cures Act signed
Codified the Breakthrough Devices Program and clarified which software functions are not devices.
View timeline milestoneEnactment, not the dates of subsequent FDA implementation or guidance.
- 21st Century Cures Act, Public Law 114-255, sections 3051 and 3060
U.S. government (govinfo.gov)
https://www.govinfo.gov/link/plaw/114/public/255
No recorded date check
- 21st Century Cures Act, Public Law 114-255, sections 3051 and 3060
· EU
MDR and IVDR enter into force
Regulations (EU) 2017/745 and 2017/746 replaced the device directives, with multi-year transition periods and EUDAMED.
View timeline milestone- European Commission UDI system brochure, page 1: MDR/IVDR commencement dates
European Commission
https://health.ec.europa.eu/document/download/add107c5-0ca8-45d3-b049-63bb84c4ce31_en
Recorded source check:
- European Commission UDI system brochure, page 1: MDR/IVDR commencement dates
· International
Health Canada requires MDSAP
Health Canada's CMDCAS program ended on January 1, 2019 as manufacturers of Class II, III and IV devices sold in Canada transitioned to MDSAP. Existing licence holders had to submit documented transition evidence by December 31, 2018; accepted arrangements allowed some MDSAP audits to take place during 2019.
View timeline milestoneHealth Canada's transition FAQ, questions 1, 3 and 8, distinguishes the January 1, 2019 program change from the December 31, 2018 evidence deadline. Question 7 exempts distributors, retailers and private-label manufacturers from needing their own MDSAP certificate, while their original equipment manufacturer remains subject to the requirements. This is a Canadian requirement, not a common implementation date for Japan or the other MDSAP countries.
- Health Canada MDSAP transition FAQ: evidence deadline, 2019 transition options and end of CMDCAS
Government of Canada
https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/activities/international/notice-transition-plan-medical-device-audit-program.html
Recorded source check:
- Health Canada MDSAP transition FAQ: evidence deadline, 2019 transition options and end of CMDCAS
· International
ISO 14971:2019 published
Third edition of the risk management standard for medical devices.
View timeline milestone- ISO: ISO 14971:2019 published
ISO
https://www.iso.org/standard/72704.html
Recorded source check:
- ISO: ISO 14971:2019 published
· EU
EU MDR date of application
The MDR became generally applicable, including Article 117 for drug-device combinations, with separate conditional transition periods for eligible legacy devices.
View timeline milestone- European Commission UDI system brochure, page 1: MDR/IVDR commencement dates
European Commission
https://health.ec.europa.eu/document/download/add107c5-0ca8-45d3-b049-63bb84c4ce31_en
Recorded source check:
- European Commission UDI system brochure, page 1: MDR/IVDR commencement dates
· International
IEC 81001-5-1 published
Security activities for the health software product life cycle, now a key reference for device cybersecurity.
View timeline milestone- ISO: IEC 81001-5-1 published
ISO
https://www.iso.org/standard/76097.html
Recorded source check:
- ISO: IEC 81001-5-1 published
· EU
EU IVDR date of application
The IVDR became applicable, with staggered transition deadlines by risk class.
View timeline milestone- European Commission UDI system brochure, page 1: MDR/IVDR commencement dates
European Commission
https://health.ec.europa.eu/document/download/add107c5-0ca8-45d3-b049-63bb84c4ce31_en
Recorded source check:
- European Commission UDI system brochure, page 1: MDR/IVDR commencement dates
· EU
MDR transition extended
Regulation (EU) 2023/607 extended MDR transition periods for legacy devices to 2027 or 2028, depending on class.
View timeline milestone- European Union (EUR-Lex): MDR transition extended
European Union (EUR-Lex)
https://eur-lex.europa.eu/eli/reg/2023/607/oj
Recorded source check:
- European Union (EUR-Lex): MDR transition extended
· US
Section 524B cyber requirements apply
Under FDORA, submissions for cyber devices must include a cybersecurity plan, design controls and an SBOM.
View timeline milestone- FDA: Section 524B cyber requirements apply
FDA
https://www.fda.gov/medical-devices/digital-health-center-excellence/cybersecurity
Recorded source check:
- FDA: Section 524B cyber requirements apply
· US
eSTAR required for 510(k)s
FDA began requiring 510(k) submissions in the electronic eSTAR format.
View timeline milestoneFDA's page identifies October 1, 2023 as the requirement date. The guidance revision is October 2, 2023 and includes waiver and exemption criteria.
- FDA: Electronic Submission Template for Medical Device 510(k) Submissions
FDA
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/electronic-submission-template-medical-device-510k-submissions
No recorded date check
- FDA: Electronic Submission Template for Medical Device 510(k) Submissions
· EU
EU AI Act enters into force
Regulation (EU) 2024/1689 set risk-based rules for AI, with obligations phased in over several years.
View timeline milestoneEntry into force is distinct from the phased application of AI Act obligations.
- European Commission: AI Act enters into force, 1 August 2024
European Union
https://commission.europa.eu/news-and-media/news/ai-act-enters-force-2024-08-01_en
No recorded date check
- European Commission: AI Act enters into force, 1 August 2024
· US
TCET final notice published and effective
CMS published its final TCET procedural notice, effective the same day, for certain eligible FDA-designated Breakthrough Devices. The pathway was announced on August 7, 2024.
View timeline milestone- CMS final TCET notice
U.S. government (Federal Register)
https://www.federalregister.gov/documents/2024/08/12/2024-17603/medicare-program-transitional-coverage-for-emerging-technologies
- Official GPO copy of the final TCET notice
U.S. government (govinfo.gov)
https://www.govinfo.gov/content/pkg/FR-2024-08-12/html/2024-17603.htm
Recorded source check:
- CMS final TCET notice
· US
Initial final PCCP guidance for AI devices
FDA issued its initial final AI-enabled device PCCP guidance, subsequently updated on August 18, 2025. Guidance recommendations are nonbinding.
View timeline milestone- FDA PCCP guidance: original and revised issue dates
FDA
https://www.fda.gov/media/166704/download
Recorded source check:
- FDA PCCP guidance: original and revised issue dates
· US
Court vacates FDA LDT rule
A federal court set aside FDA's rule that would have regulated laboratory-developed tests as devices.
View timeline milestone- FDA: Court vacates FDA LDT rule
FDA
https://www.fda.gov/medical-devices/in-vitro-diagnostics/laboratory-developed-tests
Recorded source check:
- FDA: Court vacates FDA LDT rule
· UK
UK post-market surveillance rules apply
MHRA guidance states that strengthened Part 4A PMS requirements apply to individual medical devices placed on the market or put into service in Great Britain from June 16, 2025, regardless of CE or UKCA marking. Earlier individual devices remain under prior PMS rules. Custom-made devices have a reduced set of obligations; Northern Ireland follows EU MDR and IVDR PMS requirements.
View timeline milestoneMHRA explicitly states June 16, 2025. SI 2024/1368 was made December 16, 2024 and regulation 1(2) says it comes into force 6 months after the day it was made; the consolidated Part 4A annotation instead records June 17, 2025. The displayed date follows MHRA's operational guidance, not a resolution of this official one-day discrepancy. The guidance also excludes specified Secretary of State authorisations from these requirements and refers in-house manufacture to separate guidance.
- MHRA PMS guidance: June 16, 2025 application date, individual-device scope and Northern Ireland
UK government / MHRA
https://www.gov.uk/government/publications/medical-devices-post-market-surveillance-requirements/introduction-and-scope
- SI 2024/1368: made date and regulation 1(2) commencement formula
UK government / MHRA
https://www.legislation.gov.uk/uksi/2024/1368/made
- UK MDR Part 4A: consolidated annotation records June 17, 2025
UK government / MHRA
https://www.legislation.gov.uk/uksi/2002/618/part/4A
Recorded source check:
- MHRA PMS guidance: June 16, 2025 application date, individual-device scope and Northern Ireland
· US
FDA updates AI device PCCP guidance
FDA issued updated final recommendations for predetermined change control plans for AI-enabled device software functions, replacing the December 4, 2024 version. This is guidance issuance, not a new statutory effective date.
View timeline milestone- FDA updated PCCP guidance
FDA
https://www.fda.gov/media/166704/download
Recorded source check:
- FDA updated PCCP guidance
· US
FDA implements LDT rule vacatur
FDA published a final rule, effective the same day, restoring the pre-May 2024 wording of 21 CFR 809.3(a) following the March 31, 2025 court vacatur.
View timeline milestone- FDA rule implementing the LDT vacatur
U.S. government (Federal Register)
https://www.federalregister.gov/documents/2025/09/19/2025-18239/regulation-identification-number-0910-aj05-medical-devices-laboratory-developed-tests-implementation
- Official GPO copy of FDA's LDT vacatur implementation rule
U.S. government (govinfo.gov)
https://www.govinfo.gov/content/pkg/FR-2025-09-19/html/2025-18239.htm
Recorded source check:
- FDA rule implementing the LDT vacatur
· US
QMSR takes effect
FDA's Quality Management System Regulation replaced the QSR, incorporating ISO 13485:2016 by reference.
View timeline milestone- FDA: QMSR takes effect
FDA
https://www.fda.gov/medical-devices/postmarket-requirements-devices/quality-management-system-regulation-qmsr
Recorded source check:
- FDA: QMSR takes effect
· EU
First four EUDAMED modules become mandatory
Actor, UDI/Device, Notified Bodies & Certificates and Market Surveillance modules became mandatory, with applicable transition provisions. Market Surveillance is for competent authorities and the Commission; the remaining modules are not yet mandatory.
View timeline milestone- European Commission EUDAMED overview
European Commission
https://health.ec.europa.eu/medical-devices-eudamed/overview_en
Recorded source check:
- European Commission EUDAMED overview
· International
Australian UDI first phase begins
UDI labelling and AusUDID data requirements began for in-scope Class IIb and III devices, subject to exclusions and transition arrangements. Other classes are phased in later.
View timeline milestone- TGA UDI commencement
TGA
https://www.tga.gov.au/news/news-articles/new-udi-requirements-medical-devices-commence-1-july-2026
Recorded source check:
- TGA UDI commencement
· EU
AI Act high-risk rules for devices
Regulation (EU) 2026/1744 amended the AI Act timetable: Article 6(1) high-risk systems tied to Annex I products, including qualifying MDR/IVDR devices requiring third-party assessment, apply from August 2, 2028, rather than the original August 2, 2027 date.
View timeline milestoneThe amended August 2, 2028 deadline has not been independently verified against the operative amendment to Article 113. EUR-Lex returned no readable text during this audit; the recorded source-check date is not verification.
- Regulation (EU) 2026/1744: amended AI Act timetable
European Union (EUR-Lex)
https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L_202601744
Recorded source check:
- Regulation (EU) 2026/1744: amended AI Act timetable
Linked documents are evidence for review, not certification of every milestone claim.